About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- USD29.68
- USD29.68
- USD28.94
- USD62.58
- -2.20%
- 36M
- 473.37k
- 686.68k
- 1.7B
- 23.42
- -5.90%
Stock News
3 hours ago
Visa’s earnings send the message that spending is still healthy
MarketWatch
yesterday
Jim Cramer says politicians should not forget ‘shareholders are a constituency’
CNBC
yesterday
Where the 'Fast Money' traders see the most promise — and problems — over President Trump's next 100 days
CNBC
yesterday
Trump tariffs squeeze businesses and may raise prices: 'Small local families are the ones paying for it,' says ice cream shop owner
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
